The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov
미국의 COVID-19 연구 환경: ClinicalTrials.Gov에 등록된 무작위 시험의 횡단면 연구
Article
[키워드] antiviral medication
Antiviral medications
antivirals
capita
Characteristics
Chloroquine
chloroquine/hydroxychloroquine
clinical endpoint
clinical trial
clinical trials
Composite
conducted
Controlled trial
COVID-19
cross-sectional
cross-sectional study
deaths
Descriptive statistics
detect
diagnosed with COVID-19
distribution
effective
evaluate
excluded
followed by
Geographic distribution
greater
highest
highlighting
Hydroxychloroquine
identify
immunomodulator
Intervention
IQR
landscape
less
lowest
measure
monoclonal antibodies
monoclonal antibody
Mortality
National
ongoing trials
pandemic
participant
pathogen
people with COVID-19
Phase 3
power
Prevent
Primary outcome
Randomized
Randomized controlled trial
Randomized controlled trials
randomized trial
randomized trials
reduction in mortality
Registered
Relative risk
resulting
risk reduction
Sample size
SARS-CoV-2
setting
severity
single trial
single-center
small molecule
Statistical power
the median
the United State
Treatment
treatments for COVID-19
Trial
trials
United States
Vaccine
Variability
Ventilation
[DOI] 10.1007/s11606-021-07167-9 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s11606-021-07167-9 PMC 바로가기 [Article Type] Article